AKTX: Gaslightwala Abizer discloses securities transactions

By AlphaYouPublished Oct 1, 2026Form 4

Stocks in this disclosure

Reported activity

Gaslightwala Abizer

Reporting filer

Gaslightwala Abizer reported Grant or award in Akari Therapeutics Plc: 6430 units of American Depositary Shares representing Ordinary Shares, dated 2026-09-29. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 1, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
American Depositary Shares representing Ordinary Shares	Gaslightwala Abizer	2026-09-29	A	Grant or award	6430	9.72	14,107	2 days	Filed terms security Title: American Depositary Shares representing Ordinary Shares transaction Date: 2026-09-29 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 6430 id: F1 transaction Price Per Share: 9.72 transaction Acquired Disposed Code: A shares Owned Following Transaction: 14107 direct Or Indirect Ownership: D

American Depositary Shares representing Ordinary Shares

Owner: Gaslightwala Abizer
Date: 2026-09-29
Code: A
Action: Grant or award
Quantity: 6430
Price: 9.72
Following holdings: 14,107
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: American Depositary Shares representing Ordinary Shares
transaction Date: 2026-09-29
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 6430
id: F1
transaction Price Per Share: 9.72
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 14107
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Gaslightwala Abizer: CEO, Director.
F1: These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. RSUs were granted on September 29, 2026 and vest in four approximately equal quarterly installments on November 18, 2026, February 18, 2027, May 18, 2027, and August 18, 2027, subject to continued service. The RSUs are subject to forfeiture and cancellation if the Issuer's shareholders do not approve an amendment to the Issuer's equity incentive plan increasing the number of shares reserved for issuance under the plan.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

American Depositary Shares representing Ordinary Shares

Gaslightwala Abizer

2026-09-29

Grant or award

6430

9.72

14,107

2 days

Filed terms

security Title: American Depositary Shares representing Ordinary Shares
transaction Date: 2026-09-29
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 6430
id: F1
transaction Price Per Share: 9.72
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 14107
direct Or Indirect Ownership: D

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Gaslightwala Abizer: CEO, Director.

F1: These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. RSUs were granted on September 29, 2026 and vest in four approximately equal quarterly installments on November 18, 2026, February 18, 2027, May 18, 2027, and August 18, 2027, subject to continued service. The RSUs are subject to forfeiture and cancellation if the Issuer's shareholders do not approve an amendment to the Issuer's equity incentive plan increasing the number of shares reserved for issuance under the plan.